URINARY CATECHOLAMINES IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER WITH AND WITHOUT COMORBID ANXIETY

被引:51
作者
PLISZKA, SR
MAAS, JW
JAVORS, MA
ROGENESS, GA
BAKER, J
机构
[1] Department of Psychiatry, University of Texas Health Science Center at San Antonio
关键词
ATTENTION-DEFICIT HYPERACTIVITY DISORDER; ANXIETY; CATECHOLAMINES; NOREPINEPHRINE; EPINEPHRINE;
D O I
10.1097/00004583-199410000-00012
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Objective: To determine whether there are differences in noradrenergic or adrenergic functioning in children with attention-deficit hyperactivity disorder (ADHD) with and without anxiety. Method: ADHD children with and without a comorbid overanxious (ANX) disorder were compared to each other and to normal controls in terms of 2-hour urinary excretion of norepinephrine (NE), epinephrine (EPI), and their metabolites. All subjects performed a fixed series of mentally stressful tasks during the collection period. Results: Children with ADHD, regardless of comorbid anxiety, excreted more normetanephrine (NMN), the chief extracellular metabolite of NE, than controls, as well as more vanillylmandelic acid. Children with ADHD alone had lower NE/NMN and EPI/metanephrine ratios compared to controls. Children with ADHD/ANX excreted more EPI than ADHD children without anxiety. Conclusions: Children with ADHD may have a higher tonic activity of the noradrenergic system than controls, while children with comorbid ADHD/ANX may be differentiated from those with ADHD alone by higher adrenergic activity.
引用
收藏
页码:1165 / 1173
页数:9
相关论文
共 39 条
[1]  
Aston-Jones G., 1990, PHARM NORADRENALINE, P187
[2]  
BARKLEY RA, 1987, BEHAV ASSESS, V9, P207
[3]  
BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728
[4]  
BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564
[5]   A 3-YEAR FOLLOW-UP OF CHILDREN WITH AND WITHOUT BEHAVIORAL-INHIBITION [J].
BIEDERMAN, J ;
ROSENBAUM, JF ;
BOLDUCMURPHY, EA ;
FARAONE, SV ;
CHALOFF, J ;
HIRSHFELD, DR ;
KAGAN, J .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1993, 32 (04) :814-821
[6]   NEUROBIOLOGICAL MECHANISMS IN HUMAN ANXIETY - EVIDENCE SUPPORTING CENTRAL NORADRENERGIC HYPERACTIVITY [J].
CHARNEY, DS ;
REDMOND, DE .
NEUROPHARMACOLOGY, 1983, 22 (12B) :1531-1536
[7]   AROUSAL AND PHYSIOLOGICAL TOUGHNESS - IMPLICATIONS FOR MENTAL AND PHYSICAL HEALTH [J].
DIENSTBIER, RA .
PSYCHOLOGICAL REVIEW, 1989, 96 (01) :84-100
[8]  
DONNELLY M, 1989, ARCH GEN PSYCHIAT, V46, P205
[9]   STIMULANT DRUG-TREATMENT OF HYPERACTIVITY - BIOCHEMICAL CORRELATES [J].
ELIA, J ;
BORCHERDING, BG ;
POTTER, WZ ;
MEFFORD, IN ;
RAPOPORT, JL ;
KEYSOR, CS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (01) :57-66
[10]   CATECHOLAMINE RESPONSE OF CHILDREN IN A NATURALLY-OCCURRING STRESSOR SITUATION [J].
ELWOOD, SW ;
FERGUSON, HB ;
THAKAR, J .
JOURNAL OF HUMAN STRESS, 1986, 12 (04) :154-161